303 related articles for article (PubMed ID: 3552281)
1. N-methyl antitumour agents. A distinct class of anticancer drugs?
Newell D; Gescher A; Harland S; Ross D; Rutty C
Cancer Chemother Pharmacol; 1987; 19(2):91-102. PubMed ID: 3552281
[TBL] [Abstract][Full Text] [Related]
2. Carbinolamines and related structures--potential alkylating metabolites of clinically active anticancer drugs.
Soloway AH; Brumbaugh RJ; Witiak DT
J Theor Biol; 1983 Jun; 102(3):361-73. PubMed ID: 6225911
[TBL] [Abstract][Full Text] [Related]
3. Triazene compounds: mechanism of action and related DNA repair systems.
Marchesi F; Turriziani M; Tortorelli G; Avvisati G; Torino F; De Vecchis L
Pharmacol Res; 2007 Oct; 56(4):275-87. PubMed ID: 17897837
[TBL] [Abstract][Full Text] [Related]
4. The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcoma.
Langdon SP; Gescher A; Hickman JA; Stevens MF
Eur J Cancer Clin Oncol; 1984 May; 20(5):699-705. PubMed ID: 6428895
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenicity of cytostatic triazenes.
Kolar GF
IARC Sci Publ; 1986; (78):111-26. PubMed ID: 3583385
[TBL] [Abstract][Full Text] [Related]
6. N-methylformamide: antitumour activity and metabolism in mice.
Gescher A; Gibson NW; Hickman JA; Langdon SP; Ross D; Atassi G
Br J Cancer; 1982 Jun; 45(6):843-50. PubMed ID: 7201320
[TBL] [Abstract][Full Text] [Related]
7. Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolism.
Ross D; Langdon SP; Gescher A; Stevens MF
Biochem Pharmacol; 1984 Apr; 33(7):1131-6. PubMed ID: 6424683
[TBL] [Abstract][Full Text] [Related]
8. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
9. Triazene metabolism. III. In vitro cytotoxicity towards M21 cells and in vivo antitumour activity of the proposed metabolites of the antitumour 1-aryl-3,3-dimethyltriazenes.
Kohlsmith DJ; Vaughan K; Luner SJ
Can J Physiol Pharmacol; 1984 Apr; 62(4):396-402. PubMed ID: 6733585
[TBL] [Abstract][Full Text] [Related]
10. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
Schmid FA; Otter GM; Mehta BM
Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of anticancer drugs.
Chabner BA; Myers CE; Oliverio VT
Semin Oncol; 1977 Jun; 4(2):165-91. PubMed ID: 69319
[No Abstract] [Full Text] [Related]
12. Cancer chemotherapy: implications for the anesthesiologist.
Selvin BL
Anesth Analg; 1981 Jun; 60(6):425-34. PubMed ID: 7015924
[No Abstract] [Full Text] [Related]
13. Biochemical and pharmacologic properties of nitrosoureas.
Wang AL; Tew KD; Byrne PJ; Schein PS
Cancer Treat Rep; 1981; 65 Suppl 3():119-24. PubMed ID: 7049367
[TBL] [Abstract][Full Text] [Related]
14. Modulating effect of new potential antimelanomic agents, spin-labeled triazenes and nitrosoureas on the DOPA-oxidase activity of tyrosinase.
Gadjeva V; Zheleva A; Raikova E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):99-108. PubMed ID: 10738906
[TBL] [Abstract][Full Text] [Related]
15. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.
Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P
Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenicity of alkylating cytostatic drugs in animals.
Berger MR
IARC Sci Publ; 1986; (78):161-76. PubMed ID: 3583389
[No Abstract] [Full Text] [Related]
17. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
Cloutier JF; Castonguay A; O'Connor TR; Drouin R
J Mol Biol; 2001 Feb; 306(2):169-88. PubMed ID: 11237592
[TBL] [Abstract][Full Text] [Related]
18. The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studies.
Coley HM; Brooks N; Phillips DH; Hewer A; Jenkins TC; Jarman M; Judson IR
Biochem Pharmacol; 1995 May; 49(9):1203-12. PubMed ID: 7763301
[TBL] [Abstract][Full Text] [Related]
19. Cytostatic action of two nitrosoureas derived from cysteamine.
Bourut C; Chenu E; Godenèche D; Madelmont JC; Maral R; Mathé G; Meyniel G
Br J Pharmacol; 1986 Nov; 89(3):539-46. PubMed ID: 3801787
[TBL] [Abstract][Full Text] [Related]
20. 1,3-Dialkyl-3-acyltriazenes, a novel class of antineoplastic alkylating agents.
Smith RH; Scudiero DA; Michejda CJ
J Med Chem; 1990 Sep; 33(9):2579-83. PubMed ID: 2391696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
